The exact pathomechanisms in AMD are unclear, with known loss of conventional RGCs in advanced stages of AMD
43; previous histologic studies did not study ipRGCs as they have been only recently discovered.
7 The relative numbers of different subtypes of ipRGCs may vary between species. There are at least five ipRGC subtypes (M1–M5) that have been identified in transgenic mouse models based on their dendritic stratification that varies across the outer and inner laminae of the inner plexiform layer (IPL).
9 IpRGC dendrites express melanopsin and have comparable photon capture to the soma
52 while also receiving synapses from bipolar and amacrine cells for signaling between outer and inner retina.
9,53,54 There is evidence of at least three ipRGC subtypes in primates,
10,55 but it is unknown how these different subtypes are affected by retinal and optic nerve disease. In rodent studies of retinal disease, Royal College of Surgeons dystrophic rats and P23H transgenic rats were used to investigate melanopsin cell function in retinitis pigmentosa.
35,56 One study showed that some ipRGCs were lost with disease progression while a significant number of ipRGCs survived into advanced stages of degeneration in the far peripheral retina.
35 A second study showed progressive loss in density, cell integrity and dendritic arborization of ipRGCs in advanced stages of retinitis pigmentosa,
56 consistent with initial findings of ipRGC dysfunction in advanced AMD.
11 A number of rodent
57–59 and human
60–62 studies show that ipRGCs are more resistant compared to conventional retinal ganglion cells in optic nerve disease and a recent study in a rat model showed that density and dendritic arborization does not change with age.
63 An example of this resistance to damage is shown in a study in patients with glaucoma that demonstrated the PIPR in patients with early glaucoma was similar to controls
29 but lower in patients with advanced glaucoma.
29,30 In patients with Leber's hereditary optic neuropathy (LHON), the sustained pupil response to blue light in the affected eye was similar to that in the healthy eye, suggesting a resistance to the intracellular metabolic disorder affecting the optic nerve caused by a genetic defect.
34,64 This is confirmed in a histologic study of LHON that showed relative sparing of ipRGCs compared to other retinal ganglion cells.
60 Although ipRGCs remained robust to early changes in diseases affecting the optic nerve or peripheral retina,
44 we hypothesize that ipRGCs may be more vulnerable in diseases affecting the central retina such as AMD.
42 No histologic study has investigated ipRGC distribution and potential loss in AMD and our research findings suggest that due to their low number and paracentral location,
10 ipRGC damage may become manifest early in the condition.